Primary aldosteronism (PA), the most common form of secondary hypertension, can be
either surgically cured or treated with targeted pharmacotherapy. PA is frequently …

Objective: Our objective was to develop clinical practice guidelines for the diagnosis and
treatment of patients with primary aldosteronism. Participants: The Task Force comprised a …

Abstract Primary aldosteronism affects 5–13% of patients with hypertension. Patients with
hypertension and hypokalemia and most patients with treatment-resistant hypertension …

Since its initial description in 1955, primary aldosteronism was thought to be a rare cause of
hypertension. However, with improved screening methodologies, it appears that primary …

Objective: To develop clinical practice guidelines for the management of patients with
primary aldosteronism. Participants: The Task Force included a chair, selected by the …

Many cases of potentially curable primary aldosteronism are currently likely to be diagnosed
as essential hypertension unless screening tests based on suppression of renin are carried …

Primary aldosteronism (PA), a common, albeit markedly underdiagnosed cause of curable
arterial hypertension, is characterized by plasma levels of aldosterone that are inappropriate …

Primary aldosteronism (PA) is the most common secondary form of arterial hypertension,
with a particularly high prevalence among patients with resistant hypertension. Aldosterone …

Since its initial description in 1955, primary aldosteronism was thought to be a rare cause of
hypertension. However, with improved screening methodologies, it appears that primary …

Primary aldosteronism is much more common than previously thought. The high prevalence
of primary aldosteronism, the damage this condition does to the heart, blood vessels and …